Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccine During Pregnancy for Prevention of Respiratory Syncytial Virus Among Infants in Argentina

Abstract Introduction Lower respiratory tract illness (LRTI) caused by respiratory syncytial virus (RSV) is common among young children in Argentina. Use of the currently available prophylactic agent is limited to children aged ≤ 2 years with selected high-risk conditions, and thus the majority of i...

Full description

Bibliographic Details
Published in:Infectious Diseases and Therapy
Main Authors: Lucila Rey-Ares, Ahuva Averin, Nadia Zuccarino, Celina Guadalupe Vega, Emily Kutrieb, Erin Quinn, Mark Atwood, Derek Weycker, Amy W. Law
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-10-01
Subjects:
Cost-effectiveness
Respiratory syncytial virus
Vaccination
Maternal
Infant
Online Access:https://doi.org/10.1007/s40121-024-01055-5

Internet

https://doi.org/10.1007/s40121-024-01055-5

Similar Items